Literature DB >> 23503607

Autoimmunity and persistent RAS-mutated clones long after the spontaneous regression of JMML.

M Takagi, J Piao, L Lin, H Kawaguchi, C Imai, A Ogawa, A Watanabe, K Akiyama, C Kobayashi, M Mori, K Ko, M Sugimoto, S Mizutani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23503607     DOI： 10.1038/leu.2013.82

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

Review 1.  JMML genomics and decisions.

Authors:  Charlotte M Niemeyer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Adults with germline CBL mutation complicated with juvenile myelomonocytic leukemia at infancy.

Authors:  Michiko Muraoka; Chiho Okuma; Kiichiro Kanamitsu; Hisashi Ishida; Yui Kanazawa; Kana Washio; Masafumi Seki; Motohiro Kato; Junko Takita; Yusuke Sato; Seishi Ogawa; Hirokazu Tsukahara; Megumi Oda; Akira Shimada
Journal:  J Hum Genet       Date:  2016-02-25       Impact factor: 3.172

3.  Somatic mosaicism for a NRAS mutation associates with disparate clinical features in RAS-associated leukoproliferative disease: a report of two cases.

Authors:  Mitsutaka Shiota; Xi Yang; Mei Kubokawa; Tatsuya Morishima; Kuniaki Tanaka; Masamitsu Mikami; Kenichi Yoshida; Masako Kikuchi; Kazushi Izawa; Ryuta Nishikomori; Yusuke Okuno; Xian Wang; Hirotoshi Sakaguchi; Hideki Muramatsu; Seiji Kojima; Satoru Miyano; Seishi Ogawa; Masatoshi Takagi; Daisuke Hata; Hirokazu Kanegane
Journal:  J Clin Immunol       Date:  2015-04-21       Impact factor: 8.317

Review 4.  Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia.

Authors:  Christian Flotho
Journal:  Epigenetics       Date:  2019-03-08       Impact factor: 4.528

Review 5.  JMML and RALD (Ras-associated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities.

Authors:  Katherine R Calvo; Susan Price; Raul C Braylan; Joao Bosco Oliveira; Michael Lenardo; Thomas A Fleisher; V Koneti Rao
Journal:  Blood       Date:  2015-02-17       Impact factor: 22.113

Review 6.  Pediatric Neoplasms Presenting with Monocytosis.

Authors:  Jacob R Greenmyer; Mira Kohorst
Journal:  Curr Hematol Malig Rep       Date:  2021-02-25       Impact factor: 3.952

Review 7.  Turning the tide in myelodysplastic/myeloproliferative neoplasms.

Authors:  Michael W N Deininger; Jeffrey W Tyner; Eric Solary
Journal:  Nat Rev Cancer       Date:  2017-06-23       Impact factor: 60.716

8.  Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network.

Authors:  Aurélie Caye; Marion Strullu; Fabien Guidez; Bruno Cassinat; Steven Gazal; Odile Fenneteau; Elodie Lainey; Kazem Nouri; Saeideh Nakhaei-Rad; Radovan Dvorsky; Julie Lachenaud; Sabrina Pereira; Jocelyne Vivent; Emmanuelle Verger; Dominique Vidaud; Claire Galambrun; Capucine Picard; Arnaud Petit; Audrey Contet; Marilyne Poirée; Nicolas Sirvent; Françoise Méchinaud; Dalila Adjaoud; Catherine Paillard; Brigitte Nelken; Yves Reguerre; Yves Bertrand; Dieter Häussinger; Jean-Hugues Dalle; Mohammad Reza Ahmadian; André Baruchel; Christine Chomienne; Hélène Cavé
Journal:  Nat Genet       Date:  2015-10-12       Impact factor: 38.330

9.  Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis.

Authors:  Elisabetta Flex; Mamta Jaiswal; Francesca Pantaleoni; Simone Martinelli; Marion Strullu; Eyad K Fansa; Aurélie Caye; Alessandro De Luca; Francesca Lepri; Radovan Dvorsky; Luca Pannone; Stefano Paolacci; Si-Cai Zhang; Valentina Fodale; Gianfranco Bocchinfuso; Cesare Rossi; Emma M M Burkitt-Wright; Andrea Farrotti; Emilia Stellacci; Serena Cecchetti; Rosangela Ferese; Lisabianca Bottero; Silvana Castro; Odile Fenneteau; Benoît Brethon; Massimo Sanchez; Amy E Roberts; Helger G Yntema; Ineke Van Der Burgt; Paola Cianci; Marie-Louise Bondeson; Maria Cristina Digilio; Giuseppe Zampino; Bronwyn Kerr; Yoko Aoki; Mignon L Loh; Antonio Palleschi; Elia Di Schiavi; Alessandra Carè; Angelo Selicorni; Bruno Dallapiccola; Ion C Cirstea; Lorenzo Stella; Martin Zenker; Bruce D Gelb; Hélène Cavé; Mohammad R Ahmadian; Marco Tartaglia
Journal:  Hum Mol Genet       Date:  2014-04-04       Impact factor: 6.150

10.  Juvenile myelomonocytic leukemia in the molecular era: a clinician's guide to diagnosis, risk stratification, and treatment.

Authors:  Astrid Wintering; Christopher C Dvorak; Elliot Stieglitz; Mignon L Loh
Journal:  Blood Adv       Date:  2021-11-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.